TITLE

Zomig

AUTHOR(S)
Goetzl, David
PUB. DATE
June 2000
SOURCE
Advertising Age;6/26/2000, Vol. 71 Issue 27, ps10
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the success of the Zeneca Pharmaceuticals prescription migraine drug Zomig. Leadership of Mike Toupe in the marketing of the drug; Advertising campaign for the drug; Death of Toupe from leukemia.
ACCESSION #
3250197

 

Related Articles

  • Zeneca ready to quit chemicals?  // Chemical Week;3/15/1995, Vol. 156 Issue 10, p6 

    Reports that Zeneca's withdrawal of its bid for Wellcome may indicate willingness to quit the chemicals business to become a bigger player in pharmaceutical.

  • Zeneca invests in U.K. pharmaceuticals.  // Chemical Week;8/2/1995, Vol. 157 Issue 4, p22 

    Reports on Zeneca Pharmaceutical Group's planned investment at its facility in Macclesfield, England.

  • Zeneca moves to protect pension funds assets. Chernoff, Joel // Pensions & Investments;8/4/1997, Vol. 25 Issue 16, p16 

    Reports on Zeneca Group P.L.C's innovative protection strategy. Information on the loss of tax credit; Details on Zeneca's gambit design; Strategies to help Zeneca overcome a mismatch between its long-term policy benchmark and its MFR benchmark; Comments from Bill Goodsall, managing director of...

  • Conference discusses on-going termite problems.  // Pest Control;Nov95, Vol. 63 Issue 11, p25 

    Highlights the 1995 Zeneca Professional Products National Termite Control Workshop. Termite damage losses; Problems of pest control operators; New construction and pretreats.

  • Non-toxic rodent bait.  // Journal of Property Management;Mar/Apr96, Vol. 61 Issue 2, p79 

    Reports on the introduction of the Census Bait Block by Zeneca Professional Products which is a subsidiary of the Zeneca Group PLC.

  • Zeneca cuts seeds but enters genome technologies.  // Nature;8/11/1994, Vol. 370 Issue 6489, p406 

    Reports on the withdrawal of Zeneca Group plc from its hybrids seeds business and its entry into the field of genome technologies. Profits; Difficulties in the drug market in the United States; Purpose of splitting Imperial Chemical Industries; Zeneca's introduction of a genetically engineered...

  • Zeneca details R&D pipeline. Rotman, David // Chemical Week;12/20/1995, Vol. 157 Issue 24, p17 

    Reports on Zeneca's announcement to commercialize its agrochemical products. Reflection of the agrochemical market's bullishness in the company's decision; Fungicide 5504 as the key to Zeneca's growth plans; Technology investment plans.

  • Zeneca unit on the block?  // Chemical Week;12/20/1995, Vol. 157 Issue 24, p28 

    Reports on speculations that Zeneca will sell its specialty inks business in Winston Salem, North Carolina. Failure of the company to secure a buyer; Reasons given for selling the business; Comments.

  • Zeneca to sell textile dyes business? Alperowicz, Natasha // Chemical Week;12/6/1995, Vol. 157 Issue 22, p22 

    Reports on Zeneca's rumored plan to sell its textile dyes business. Sales of the textile dyes business in 1993; Location of the company's textile dyes plant.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics